Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663‑8501, Japan.
Department of Genetics, Hyogo College of Medicine, Nishinomiya, Hyogo 663‑8501, Japan.
Mol Med Rep. 2019 Nov;20(5):4331-4339. doi: 10.3892/mmr.2019.10662. Epub 2019 Sep 10.
Osteoclasts (OCs) differentiate from monocyte/macrophage‑lineage hematopoietic precursor cells, which are known as OC precursors (OCPs). Several studies have investigated cell chemotaxis in the bone microenvironment; however, OCP migration ability in the bone microenvironment during OC differentiation is yet to be elucidated. As an initial investigation of this characteristic, the present study aimed to determine the effects of transforming growth factor (TGF)‑β1 on OCP migration in vitro. Pre‑osteoclastic RAW264.7 cells were cultured with and without TGF‑β1 (2, 5 or 20 ng/ml), receptor activator of NF‑κB ligand (RANKL; 50 ng/ml), and/or SB431542 (10 µM), a potent and specific inhibitor of TGF‑β1 receptor kinase activity. Cell proliferation was significantly inhibited in the presence of TGF‑β1 for 3 days, and the effect was reversed by SB431542. Tartrate‑resistant acid phosphatase (TRAP) activity in RAW264.7 cells was significantly increased by RANKL treatment, compared with TRAP activity in control cells on day 3. The highest TRAP activity in RAW264.7 cells was induced by the combined treatment with TGF‑β1 (2 ng/ml) and RANKL. When TGF‑β1 signaling was inhibited by addition of SB431542 to the medium during culture, OC differentiation was notably suppressed. These findings suggest that TGF‑β1 accelerates RANKL‑induced OC differentiation, but does not act in a dose‑dependent manner. The migration of RAW264.7 cells was promoted at 24 h, but was suppressed at 72 h, during RANKL‑induced osteoclast differentiation in the presence of TGF‑β1. These results were accompanied with the increased expression of small G‑proteins, RhoA and Rac, at 24 h, but their expression decreased at 72 h. RAW264.7 cells treated with TGF‑β1 for 24 h underwent morphological changes, from round to polygonal morphology. Furthermore, protrusions were completely lost and the cell morphology reverted from polygonal to round after TGF‑β1 treatment for 72 h. Therefore, our findings indicated that OCP migration may be modified by differentiation in vitro.
破骨细胞(OCs)起源于单核/巨噬细胞谱系造血前体细胞,这些细胞被称为 OC 前体(OCPs)。已有多项研究调查了骨微环境中的细胞趋化性;然而,OC 分化过程中 OCP 在骨微环境中的迁移能力尚未阐明。作为对该特征的初步研究,本研究旨在确定转化生长因子(TGF)-β1 对体外 OCP 迁移的影响。用和不用 TGF-β1(2、5 或 20ng/ml)、核因子-κB 配体受体激活剂(RANKL;50ng/ml)和/或 SB431542(10µM,TGF-β1 受体激酶活性的有效和特异抑制剂)培养前破骨细胞 RAW264.7 细胞。TGF-β1 存在 3 天时,细胞增殖明显受到抑制,而 SB431542 可逆转该作用。与第 3 天对照细胞的酒石酸抗性酸性磷酸酶(TRAP)活性相比,RANKL 处理可显著增加 RAW264.7 细胞的 TRAP 活性。用 2ng/ml TGF-β1 和 RANKL 联合处理 RAW264.7 细胞可诱导最高的 TRAP 活性。在培养过程中,通过向培养基中添加 SB431542 抑制 TGF-β1 信号转导时,OC 分化明显受到抑制。这些发现表明,TGF-β1 加速 RANKL 诱导的 OC 分化,但不是呈剂量依赖性方式。在 RANKL 诱导的破骨细胞分化过程中,TGF-β1 的存在可促进 24 小时 RAW264.7 细胞的迁移,但抑制 72 小时的迁移。在 24 小时时,这些结果伴随着小 G 蛋白 RhoA 和 Rac 的表达增加,但在 72 小时时其表达减少。用 TGF-β1 处理 24 小时的 RAW264.7 细胞发生形态变化,从圆形变为多边形形态。此外,在 TGF-β1 处理 72 小时后,突起完全消失,细胞形态从多边形变回圆形。因此,我们的研究结果表明,体外分化可能会改变 OCP 的迁移。